APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ramipril

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ramipril Industry Growth and Trends Forecast to 2032

20 December 2025103 pages

Choose your research edition.

Industry ResearchRamipril Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Ramipril Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Ramipril Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ramipril Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Ramipril Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ramipril market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ramipril is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ramipril is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ramipril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ramipril include Novartis, King Pharmaceuticals, Westfield Pharma, Santa Cruz Biotechnology, Sanofi-Aventis, Pharmanova, Opsonin Pharma Limited., Lek and Krka, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ramipril market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ramipril market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ramipril market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ramipril.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ramipril market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ramipril Market by Company

Novartis

King Pharmaceuticals

Westfield Pharma

Santa Cruz Biotechnology

Sanofi-Aventis

Pharmanova

Opsonin Pharma Limited.

Lek

Krka

Hemofarm

Cemelog-BRS

Arrow Pharmaceuticals

Ramipril Segment by Type

Tablet Ramipril

Capsule Ramipril

Ramipril Segment by Application

Clinic

Hospital

Others

Ramipril Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ramipril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ramipril and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ramipril.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ramipril manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ramipril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Ramipril Table 2. Major Company of Capsule Ramipril Table 3. Global Ramipril Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ramipril Sales by Type (2021-2026) & (k units) Table 5. Global Ramipril Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ramipril Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ramipril Sales Market Share in Value by Type (2021-2026) Table 8. Global Ramipril Price by Type (2021-2026) & (US$/unit) Table 9. Global Ramipril Sales by Type (2027-2032) & (k units) Table 10. Global Ramipril Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ramipril Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ramipril Sales Market Share in Value by Type (2027-2032) Table 13. Global Ramipril Price by Type (2027-2032) & (US$/unit) Table 14. North America Ramipril Sales by Type (2021-2026) & (k units) Table 15. North America Ramipril Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ramipril Sales by Type (2021-2026) & (k units) Table 17. Europe Ramipril Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ramipril Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Ramipril Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ramipril Sales by Type (2021-2026) & (k units) Table 21. Latin America Ramipril Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ramipril Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Ramipril Sales by Type (2021-2026) & (US$ Million) Table 24. Ramipril Industry Trends Table 25. Ramipril Industry Drivers Table 26. Ramipril Industry Opportunities and Challenges Table 27. Ramipril Industry Restraints Table 28. Global Ramipril Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ramipril Revenue Market Share by Company (2021-2026) Table 30. Global Ramipril Sales by Company (2021-2026) & (k units) Table 31. Global Ramipril Sales Share by Company (2021-2026) Table 32. Global Ramipril Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Ramipril Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ramipril Major Company Production Sites and Headquarters Table 35. Global Ramipril Company, Product Type & Application Table 36. Global Ramipril Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ramipril by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ramipril Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ramipril Sales by Region (2021-2026) & (k units) Table 41. Global Ramipril Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ramipril Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ramipril Sales Market Share in Value by Region (2021-2026) Table 44. Global Ramipril Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Ramipril Sales by Region (2027-2032) & (k units) Table 46. Global Ramipril Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ramipril Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ramipril Sales Market Share in Value by Region (2027-2032) Table 49. Global Ramipril Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Ramipril Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ramipril Sales by Application (2021-2026) & (k units) Table 52. Global Ramipril Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ramipril Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ramipril Sales Market Share in Value by Application (2021-2026) Table 55. Global Ramipril Price by Application (2021-2026) & (US$/unit) Table 56. Global Ramipril Sales by Application (2027-2032) & (k units) Table 57. Global Ramipril Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ramipril Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ramipril Sales Market Share in Value by Application (2027-2032) Table 60. Global Ramipril Price by Application (2027-2032) & (US$/unit) Table 61. North America Ramipril Sales by Application (2021-2026) & (k units) Table 62. North America Ramipril Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ramipril Sales by Application (2021-2026) & (k units) Table 64. Europe Ramipril Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ramipril Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Ramipril Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ramipril Sales by Application (2021-2026) & (k units) Table 68. Latin America Ramipril Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ramipril Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Ramipril Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novartis Ramipril Product Portfolio Table 75. Novartis Recent Development Table 76. King Pharmaceuticals Company Information Table 77. King Pharmaceuticals Business Overview Table 78. King Pharmaceuticals Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. King Pharmaceuticals Ramipril Product Portfolio Table 80. King Pharmaceuticals Recent Development Table 81. Westfield Pharma Company Information Table 82. Westfield Pharma Business Overview Table 83. Westfield Pharma Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Westfield Pharma Ramipril Product Portfolio Table 85. Westfield Pharma Recent Development Table 86. Santa Cruz Biotechnology Company Information Table 87. Santa Cruz Biotechnology Business Overview Table 88. Santa Cruz Biotechnology Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Santa Cruz Biotechnology Ramipril Product Portfolio Table 90. Santa Cruz Biotechnology Recent Development Table 91. Sanofi-Aventis Company Information Table 92. Sanofi-Aventis Business Overview Table 93. Sanofi-Aventis Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Sanofi-Aventis Ramipril Product Portfolio Table 95. Sanofi-Aventis Recent Development Table 96. Pharmanova Company Information Table 97. Pharmanova Business Overview Table 98. Pharmanova Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Pharmanova Ramipril Product Portfolio Table 100. Pharmanova Recent Development Table 101. Opsonin Pharma Limited. Company Information Table 102. Opsonin Pharma Limited. Business Overview Table 103. Opsonin Pharma Limited. Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Opsonin Pharma Limited. Ramipril Product Portfolio Table 105. Opsonin Pharma Limited. Recent Development Table 106. Lek Company Information Table 107. Lek Business Overview Table 108. Lek Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Lek Ramipril Product Portfolio Table 110. Lek Recent Development Table 111. Krka Company Information Table 112. Krka Business Overview Table 113. Krka Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Krka Ramipril Product Portfolio Table 115. Krka Recent Development Table 116. Hemofarm Company Information Table 117. Hemofarm Business Overview Table 118. Hemofarm Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Hemofarm Ramipril Product Portfolio Table 120. Hemofarm Recent Development Table 121. Cemelog-BRS Company Information Table 122. Cemelog-BRS Business Overview Table 123. Cemelog-BRS Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Cemelog-BRS Ramipril Product Portfolio Table 125. Cemelog-BRS Recent Development Table 126. Arrow Pharmaceuticals Company Information Table 127. Arrow Pharmaceuticals Business Overview Table 128. Arrow Pharmaceuticals Ramipril Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Arrow Pharmaceuticals Ramipril Product Portfolio Table 130. Arrow Pharmaceuticals Recent Development Table 131. North America Ramipril Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. North America Ramipril Sales by Country (2021-2026) & (k units) Table 133. North America Ramipril Sales Market Share by Country (2021-2026) Table 134. North America Ramipril Sales Forecast by Country (2027-2032) & (k units) Table 135. North America Ramipril Sales Market Share Forecast by Country (2027-2032) Table 136. North America Ramipril Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Ramipril Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Ramipril Market Share by Country (2021-2026) Table 139. North America Ramipril Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Ramipril Market Share Forecast by Country (2027-2032) Table 141. Europe Ramipril Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Europe Ramipril Sales by Country (2021-2026) & (k units) Table 143. Europe Ramipril Sales Market Share by Country (2021-2026) Table 144. Europe Ramipril Sales Forecast by Country (2027-2032) & (k units) Table 145. Europe Ramipril Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Ramipril Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Ramipril Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Ramipril Market Share by Country (2021-2026) Table 149. Europe Ramipril Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Ramipril Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Ramipril Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Ramipril Sales by Country (2021-2026) & (k units) Table 153. Asia-Pacific Ramipril Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Ramipril Sales Forecast by Country (2027-2032) & (k units) Table 155. Asia-Pacific Ramipril Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Ramipril Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Ramipril Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Ramipril Market Share by Country (2021-2026) Table 159. Asia-Pacific Ramipril Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Ramipril Market Share Forecast by Country (2027-2032) Table 161. Latin America Ramipril Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Latin America Ramipril Sales by Country (2021-2026) & (k units) Table 163. Latin America Ramipril Sales Market Share by Country (2021-2026) Table 164. Latin America Ramipril Sales Forecast by Country (2027-2032) & (k units) Table 165. Latin America Ramipril Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Ramipril Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Ramipril Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Ramipril Market Share by Country (2021-2026) Table 169. Latin America Ramipril Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Ramipril Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Ramipril Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Ramipril Sales by Country (2021-2026) & (k units) Table 173. Middle East and Africa Ramipril Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Ramipril Sales Forecast by Country (2027-2032) & (k units) Table 175. Middle East and Africa Ramipril Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Ramipril Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Ramipril Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Ramipril Market Share by Country (2021-2026) Table 179. Middle East and Africa Ramipril Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Ramipril Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Ramipril Distributors List Table 184. Ramipril Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Ramipril Image Figure 2. Global Ramipril Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ramipril Market Size (2021-2032) & (US$ Million) Figure 4. Global Ramipril Sales (2021-2032) & (k units) Figure 5. Tablet Ramipril Image Figure 6. Global Tablet Ramipril Sales YoY Growth (2021-2032) & (k units) Figure 7. Capsule Ramipril Image Figure 8. Global Capsule Ramipril Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Ramipril Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ramipril Market Share by Type 2025 VS 2032 Figure 11. North America Ramipril Sales Market Share in Volume by Type in 2025 Figure 12. North America Ramipril Sales Market Share in Value by Type in 2025 Figure 13. Europe Ramipril Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ramipril Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ramipril Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ramipril Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ramipril Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ramipril Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ramipril Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ramipril Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ramipril Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinic Image Figure 24. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Ramipril Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Ramipril Market Share by Application 2025 VS 2032 Figure 31. North America Ramipril Sales Market Share in Volume by Application in 2025 Figure 32. North America Ramipril Sales Market Share in Value by Application in 2025 Figure 33. Europe Ramipril Sales Market Share in Volume by Application in 2025 Figure 34. Europe Ramipril Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Ramipril Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Ramipril Sales Market Share in Value by Application in 2025 Figure 37. Latin America Ramipril Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Ramipril Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Ramipril Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Ramipril Sales Market Share in Value by Application in 2025 Figure 41. North America Ramipril Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Ramipril Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Ramipril Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Ramipril Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ramipril Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Ramipril Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ramipril Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Ramipril Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ramipril Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Ramipril Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ramipril Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Ramipril Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ramipril Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Ramipril Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ramipril Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Ramipril Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ramipril Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Ramipril Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ramipril Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Ramipril Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Ramipril Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Ramipril Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet Ramipril
  • Capsule Ramipril
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Novartis
  • King Pharmaceuticals
  • Westfield Pharma
  • Santa Cruz Biotechnology
  • Sanofi-Aventis
  • Pharmanova
  • Opsonin Pharma Limited.
  • Lek
  • Krka
  • Hemofarm
  • Cemelog-BRS
  • Arrow Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ramipril Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ramipril Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ramipril Market by Type
  6. 1.3.1 Tablet Ramipril
  7. 1.3.2 Capsule Ramipril
  8. 1.4 Global Ramipril Market Size by Type
  9. 1.4.1 Global Ramipril Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ramipril Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ramipril Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ramipril Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ramipril Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ramipril Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ramipril Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ramipril Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ramipril Industry Trends
  2. 2.2 Ramipril Industry Drivers
  3. 2.3 Ramipril Industry Opportunities and Challenges
  4. 2.4 Ramipril Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ramipril Revenue (2021-2026)
  2. 3.2 Global Top Players by Ramipril Sales (2021-2026)
  3. 3.3 Global Top Players by Ramipril Price (2021-2026)
  4. 3.4 Global Ramipril Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ramipril Major Company Production Sites & Headquarters
  6. 3.6 Global Ramipril Company, Product Type & Application
  7. 3.7 Global Ramipril Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ramipril Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ramipril Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ramipril Tier 1, Tier 2, and Tier 3
4 Ramipril Regional Status and Outlook
  1. 4.1 Global Ramipril Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ramipril Historic Market Size by Region
  3. 4.2.1 Global Ramipril Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ramipril Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ramipril Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ramipril Forecasted Market Size by Region
  7. 4.3.1 Global Ramipril Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ramipril Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ramipril Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ramipril by Application
  1. 5.1 Ramipril Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Ramipril Market Size by Application
  6. 5.2.1 Global Ramipril Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ramipril Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ramipril Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ramipril Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ramipril Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ramipril Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ramipril Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ramipril Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Ramipril Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Ramipril Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 King Pharmaceuticals
  8. 6.2.1 King Pharmaceuticals Company Information
  9. 6.2.2 King Pharmaceuticals Business Overview
  10. 6.2.3 King Pharmaceuticals Ramipril Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 King Pharmaceuticals Ramipril Product Portfolio
  12. 6.2.5 King Pharmaceuticals Recent Developments
  13. 6.3 Westfield Pharma
  14. 6.3.1 Westfield Pharma Company Information
  15. 6.3.2 Westfield Pharma Business Overview
  16. 6.3.3 Westfield Pharma Ramipril Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Westfield Pharma Ramipril Product Portfolio
  18. 6.3.5 Westfield Pharma Recent Developments
  19. 6.4 Santa Cruz Biotechnology
  20. 6.4.1 Santa Cruz Biotechnology Company Information
  21. 6.4.2 Santa Cruz Biotechnology Business Overview
  22. 6.4.3 Santa Cruz Biotechnology Ramipril Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Santa Cruz Biotechnology Ramipril Product Portfolio
  24. 6.4.5 Santa Cruz Biotechnology Recent Developments
  25. 6.5 Sanofi-Aventis
  26. 6.5.1 Sanofi-Aventis Company Information
  27. 6.5.2 Sanofi-Aventis Business Overview
  28. 6.5.3 Sanofi-Aventis Ramipril Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi-Aventis Ramipril Product Portfolio
  30. 6.5.5 Sanofi-Aventis Recent Developments
  31. 6.6 Pharmanova
  32. 6.6.1 Pharmanova Company Information
  33. 6.6.2 Pharmanova Business Overview
  34. 6.6.3 Pharmanova Ramipril Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pharmanova Ramipril Product Portfolio
  36. 6.6.5 Pharmanova Recent Developments
  37. 6.7 Opsonin Pharma Limited.
  38. 6.7.1 Opsonin Pharma Limited. Company Information
  39. 6.7.2 Opsonin Pharma Limited. Business Overview
  40. 6.7.3 Opsonin Pharma Limited. Ramipril Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Opsonin Pharma Limited. Ramipril Product Portfolio
  42. 6.7.5 Opsonin Pharma Limited. Recent Developments
  43. 6.8 Lek
  44. 6.8.1 Lek Company Information
  45. 6.8.2 Lek Business Overview
  46. 6.8.3 Lek Ramipril Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lek Ramipril Product Portfolio
  48. 6.8.5 Lek Recent Developments
  49. 6.9 Krka
  50. 6.9.1 Krka Company Information
  51. 6.9.2 Krka Business Overview
  52. 6.9.3 Krka Ramipril Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Krka Ramipril Product Portfolio
  54. 6.9.5 Krka Recent Developments
  55. 6.10 Hemofarm
  56. 6.10.1 Hemofarm Company Information
  57. 6.10.2 Hemofarm Business Overview
  58. 6.10.3 Hemofarm Ramipril Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hemofarm Ramipril Product Portfolio
  60. 6.10.5 Hemofarm Recent Developments
  61. 6.11 Cemelog-BRS
  62. 6.11.1 Cemelog-BRS Company Information
  63. 6.11.2 Cemelog-BRS Business Overview
  64. 6.11.3 Cemelog-BRS Ramipril Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cemelog-BRS Ramipril Product Portfolio
  66. 6.11.5 Cemelog-BRS Recent Developments
  67. 6.12 Arrow Pharmaceuticals
  68. 6.12.1 Arrow Pharmaceuticals Company Information
  69. 6.12.2 Arrow Pharmaceuticals Business Overview
  70. 6.12.3 Arrow Pharmaceuticals Ramipril Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Arrow Pharmaceuticals Ramipril Product Portfolio
  72. 6.12.5 Arrow Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Ramipril Sales by Country
  2. 7.1.1 North America Ramipril Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ramipril Sales by Country (2021-2026)
  4. 7.1.3 North America Ramipril Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ramipril Market Size by Country
  6. 7.2.1 North America Ramipril Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ramipril Market Size by Country (2021-2026)
  8. 7.2.3 North America Ramipril Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ramipril Sales by Country
  2. 8.1.1 Europe Ramipril Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ramipril Sales by Country (2021-2026)
  4. 8.1.3 Europe Ramipril Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ramipril Market Size by Country
  6. 8.2.1 Europe Ramipril Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ramipril Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ramipril Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ramipril Sales by Country
  2. 9.1.1 Asia-Pacific Ramipril Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ramipril Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ramipril Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ramipril Market Size by Country
  6. 9.2.1 Asia-Pacific Ramipril Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ramipril Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ramipril Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ramipril Sales by Country
  2. 10.1.1 South America Ramipril Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ramipril Sales by Country (2021-2026)
  4. 10.1.3 South America Ramipril Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ramipril Market Size by Country
  6. 10.2.1 South America Ramipril Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ramipril Market Size by Country (2021-2026)
  8. 10.2.3 South America Ramipril Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ramipril Sales by Country
  2. 11.1.1 Middle East and Africa Ramipril Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ramipril Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ramipril Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ramipril Market Size by Country
  6. 11.2.1 Middle East and Africa Ramipril Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ramipril Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ramipril Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ramipril Value Chain Analysis
  2. 12.1.1 Ramipril Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ramipril Production Mode & Process
  7. 12.2 Ramipril Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ramipril Distributors
  10. 12.2.3 Ramipril Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst